This week in Geneva for the first time ever, the WHO drugs committee has heard the voices of doctors, patients, and researchers, and started to weigh the harms and benefits of Cannabis neutrally.
Pre & Critical reviews: insights into the processes of the WHO scientific abuse liability assessment for drugs.
In 2018 for the first time, the World Health Organization is assessing the medical uses and harms of Cannabis, and will recommend the suitable classification to be applied internationally. We promote an objective and independent assessment, that recognizes and acknowledges modern research on Cannabis. Support us!
The crimson papers are a series of short documents aimed at sharing knowledge regarding the process of scheduling plants, medicines and substances within the international drug control treaty framework.
